Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal-Bolus Insulin: Phase 4 OPTIMIZE Study.
Chantal MathieuS John WeisnagelPeter StellaJacques BruhwylerKathy AlexandrePublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
EudraCT number: 2015-001186-46.